Skip to main content
VCbacked
Log inGet Started

Immunitas Therapeutics

Cambridge, United States

Immunitas Therapeutics is a single cell genomics-based drug discovery company that modulates oncology targets.

$58.0M raised
Aug 2021
Series B
BiotechnologyHealth CareLife ScienceOncologyTherapeutics

Top Investors

Longwood FundEvotecMirae AssetBlood Cancer UnitedInc.Ono Venture Investment

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Immunitas Therapeutics

How much funding has Immunitas Therapeutics raised?
Immunitas Therapeutics has raised $58.0M in total funding. The most recent round was Series B. The last funding was announced in August 2021.
Who are Immunitas Therapeutics's investors?
Immunitas Therapeutics's investors include Longwood Fund, Evotec, Mirae Asset, Blood Cancer United, Inc., Ono Venture Investment.
Where is Immunitas Therapeutics headquartered?
Immunitas Therapeutics is headquartered in Cambridge, United States.
What does Immunitas Therapeutics do?
Immunitas Therapeutics is a single cell genomics-based drug discovery company that modulates oncology targets.
What stage is Immunitas Therapeutics at?
Immunitas Therapeutics is at the Series B stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Immunitas Therapeutics — Funding & Investors." VCBacked, August 18, 2021, https://www.vcbacked.co/company/immunitas-therapeutics. Accessed July 2, 2026.
APA
VCBacked. (2021). Immunitas Therapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/immunitas-therapeutics
Wikipedia (cite web)
{{cite web |title=Immunitas Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/immunitas-therapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Renaissance BioScience
Vancouver$599K
Allterum Therapeutics
Houston$1.0M
Rapport Therapeutics
Boston$250.0M
AlpalifeBio
Woburn$9.8M
Epsilogen
London$16.3M
Advanced Microbiome Interventions
Amsterdam$300K